Standout Papers

Early Intensive vs a Delayed Conservative Simvastatin Strategy in Patients With Acute Coronary ... 2004 2026 2011 2018 942
  1. Early Intensive vs a Delayed Conservative Simvastatin Strategy in Patients With Acute Coronary Syndromes (2004)
    James A. de Lemos, Michael A. Blazing et al. JAMA

Immediate Impact

4 from Science/Nature 113 standout
Sub-graph 1 of 15

Citing Papers

Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial
2022 Standout
The changing landscape of atherosclerosis
2021 StandoutNature
1 intermediate paper

Works of Robin Mukherjee being referenced

Eplerenone Reduces Mortality 30 Days After Randomization Following Acute Myocardial Infarction in Patients With Left Ventricular Systolic Dysfunction and Heart Failure
2005
Early Intensive vs a Delayed Conservative Simvastatin Strategy in Patients With Acute Coronary Syndromes
2004 Standout

Author Peers

Author Last Decade Papers Cites
Robin Mukherjee 1158 860 312 1020 15 2.1k
Andrei Breazna 812 976 164 1583 29 2.6k
José Luis Zamorano 754 756 132 1585 15 2.4k
Virginia Fitzpatrick 781 853 170 1426 9 2.4k
Estella Kanevsky 632 541 214 1725 14 2.0k
Adriaan M. Kamper 795 803 257 1917 26 3.1k
Armando Lira Pineda 768 705 235 2203 20 2.6k
Jordan Fulcher 617 410 146 1004 18 1.6k
Harry Haber 1245 690 153 657 28 2.2k
Wendy Hague 613 614 239 1535 41 2.7k
Jonathan L. Isaacsohn 571 711 254 1458 50 2.3k

All Works

Loading papers...

Rankless by CCL
2026